These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 16902180

  • 1. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J.
    Circ Res; 2006 Sep 01; 99(5):528-36. PubMed ID: 16902180
    [Abstract] [Full Text] [Related]

  • 2. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, Koyama Y, Shiga R, Nozaki N, Nakajima O, Nishimaru K, Abe J, Endoh M, Walsh RA, Goto K, Kubota I.
    Circulation; 2006 Jan 03; 113(1):60-6. PubMed ID: 16380548
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
    Kagiyama S, Matsumura K, Fukuhara M, Sakagami K, Fujii K, Iida M.
    Hypertens Res; 2007 Oct 03; 30(10):979-89. PubMed ID: 18049031
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 8. Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.
    Zhai P, Yamamoto M, Galeotti J, Liu J, Masurekar M, Thaisz J, Irie K, Holle E, Yu X, Kupershmidt S, Roden DM, Wagner T, Yatani A, Vatner DE, Vatner SF, Sadoshima J.
    J Clin Invest; 2005 Nov 17; 115(11):3045-56. PubMed ID: 16276415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M, Usui S, Takagi H, Hong C, Liu J, Yokota M, Sadoshima J.
    Circ Res; 2007 May 11; 100(9):1344-52. PubMed ID: 17395874
    [Abstract] [Full Text] [Related]

  • 11. Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II.
    Porrello ER, Huggins CE, Curl CI, Domenighetti AA, Pedrazzini T, Delbridge LM, Morgan TO.
    J Renin Angiotensin Aldosterone Syst; 2004 Dec 11; 5(4):169-75. PubMed ID: 15806712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
    Howes AL, Miyamoto S, Adams JW, Woodcock EA, Brown JH.
    J Mol Cell Cardiol; 2006 May 11; 40(5):597-604. PubMed ID: 16466740
    [Abstract] [Full Text] [Related]

  • 14. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D, Kuhn C, van Eickels M, Gehring D, Hanselmann C, Lippl S, Will R, Katus HA, Frey N.
    Circulation; 2007 Nov 27; 116(22):2587-96. PubMed ID: 18025526
    [Abstract] [Full Text] [Related]

  • 15. Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.
    Itoh S, Ding B, Shishido T, Lerner-Marmarosh N, Wang N, Maekawa N, Berk BC, Takeishi Y, Yan C, Blaxall BC, Abe J.
    Circulation; 2006 Apr 11; 113(14):1787-98. PubMed ID: 16585392
    [Abstract] [Full Text] [Related]

  • 16. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J, Chen JK, Neilson EG, Harris RC.
    J Am Soc Nephrol; 2006 Jun 11; 17(6):1615-23. PubMed ID: 16641152
    [Abstract] [Full Text] [Related]

  • 17. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
    Huggins CE, Domenighetti AA, Pedrazzini T, Pepe S, Delbridge LM.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 11; 4(3):186-90. PubMed ID: 14608525
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM.
    Circulation; 2004 Apr 20; 109(15):1892-7. PubMed ID: 15051641
    [Abstract] [Full Text] [Related]

  • 19. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
    You W, Min X, Zhang X, Qian B, Pang S, Ding Z, Li C, Gao X, Di R, Cheng Y, Liu L.
    Shock; 2009 Jul 20; 32(1):108-17. PubMed ID: 19106822
    [Abstract] [Full Text] [Related]

  • 20. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.
    Circ Res; 2008 Mar 28; 102(6):720-8. PubMed ID: 18258859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.